Ideaya Biosciences Has Entered Into A Clinical Trial Collaboration And Supply Agreement With Merck To Evaluate Its IDEE161 In Combination With Keytruda (Pembrolizumab) For Endometrial Cancer, In A Phase 1 Trial
Ideaya Biosciences已與默沙東簽訂了臨床試驗合作和供應協議,以評估其 IDEE161 與 Keytruda(Pembrolizumab)聯合用於子宮內膜癌的 1 期試驗